XML 32 R14.htm IDEA: XBRL DOCUMENT
v3.24.1

Shareholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2023
Shareholders' Equity [Abstract] |
SHAREHOLDERS' EQUITY | NOTE 6 - SHAREHOLDERS’ EQUITY
| a. | Share capital:
The Company’s ordinary shares are traded in the United States on the Nasdaq Global Market, under the symbol MNDO. The Ordinary shares of the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company and the right to receive dividends, if and when, declared.
| b. | Treasury shares:
During the period between September 2008 and December 2009, the Company purchased an aggregate number of 3,165,092 ordinary shares for a total consideration of approximately $2.8 million. Currently, the Company does not have an active buyback plan. As of December 31, 2023, the remaining treasury shares are 1,475,184 ordinary shares which amounted to $1,007 thousand. The treasury shares are mainly utilized by the Company to settle exercise of options by employees. During the years ended December 31, 2023, 2022 and 2021 treasury shares were utilized in amounts of 61 thousand, 67 thousand and 72 thousand, respectively.
| c. | Dividend:
Dividends paid per share in the years ended December 31, 2023, 2022 and 2021 were $0.24, $0.26 and $0.26, respectively. The Company paid dividends to its shareholders in the total amounts of approximately $4.8 million, $5.2 million and $5.2 million during the years ended December 31, 2023, 2022 and 2021, respectively.
| d. | Stock option plan:
In 2011, the Board of Directors and the Company’s shareholders approved a ten-year share incentive plan (the “2011 Share Incentive Plan”) that was further extended by the Board of Directors for additional ten years. Under the 2011 Share Incentive Plan, options for up to 1,800,000 ordinary shares of NIS 0.01 par value can be granted to employees, directors, consultants or contractors of the Company and its subsidiaries. Each option can be exercised to purchase one ordinary share. Immediately upon issuance, the ordinary shares issuable upon the exercise of the options will confer their holders the same rights as the other ordinary shares. The Board of Directors determines the exercise price and the vesting period of the options granted. The outstanding options granted under the abovementioned plan vest over 2-4 years on service basis. Options not exercised will expire five years after the day of grant. The compensation costs charged against income for the 2011 Share Incentive Plan were comprised as follows:
|  | Years Ended December 31, |
|  | 2 0 2 3 |  |  | 2 0 2 2 |  |  | 2 0 2 1 |
|  | U.S. dollars in thousands |
Cost of revenues |  | $ | 60 |  |  | $ | 63 |  |  | $ | 49 |
Research and development expenses |  |  | 180 |  |  |  | 159 |  |  |  | 90 |
Selling and marketing expenses |  |  | 3 |  |  |  | 1 |  |  |  | 4 |
General and administrative expenses |  |  | 38 |  |  |  | 35 |  |  |  | 28 |
|  | $ | 281 |  |  | $ | 258 |  |  | $ | 171 |
Under Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 (the “Israeli Tax Ordinance”), pursuant to an election made by the Company thereunder, Israeli employees (except for employees who are deemed “Controlling Members” under the Israeli Income Tax Ordinance) are subject to a lower tax rate of 25% on part of the capital gains accruing to them in respect of Section 102 awards. However, the Company is not allowed to claim as an expense for tax purposes the amounts credited as income for tax purposes to such employees.
| 1) | The following is a summary of the status of the 2011 Share Incentive Plan as of December 31, 2023, 2022 and 2021, and changes during the years ended on those dates:
|  | Years Ended December 31, |
|  | 2 0 2 3 |  |  | 2 0 2 2 |  |  | 2 0 2 1 |
|  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |
Options outstanding at the beginning of year |  |  | 452,500 |  |  | $ | 0.003 |  |  |  | 269,500 |  |  | $ | 0.003 |  |  |  | 266,500 |  |  | $ | 0.003 |
Changes during year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted (a) |  |  | 132,000 |  |  | $ | 0.003 |  |  |  | 304,000 |  |  | $ | 0.003 |  |  |  | 172,000 |  |  | $ | 0.003 |
Exercised |  |  | (60,500 | ) |  | $ | 0.003 |  |  |  | (67,000 | ) |  | $ | 0.003 |  |  |  | (71,500 | ) |  | $ | 0.003 |
Forfeited |  |  | (15,000 | ) |  | $ | 0.003 |  |  |  | (54,000 | ) |  | $ | 0.003 |  |  |  | (96,500 | ) |  | $ | 0.003 |
Expired |  |  | (8,000 | ) |  | $ | 0.003 |  |  |  | - |  |  | $ | 0.003 |  |  |  | (1,000 | ) |  | $ | 0.003 |
Options outstanding at the end of year |  |  | 501,000 |  |  | $ | 0.003 |  |  |  | 452,500 |  |  | $ | 0.003 |  |  |  | 269,500 |  |  | $ | 0.003 |
Options exercisable at the end of year |  |  | 30,000 |  |  | $ | 0.003 |  |  |  | 25,500 |  |  | $ | 0.003 |  |  |  | 30,000 |  |  | $ | 0.003 |
Weighted average grant date fair value of options granted during the year (b) |  |  |  |  |  | $ | 1.28 |  |  |  |  |  |  | $ | 1.58 |  |  |  |  |  |  | $ | 1.79 |
(a) | In the years ended December 31, 2023 and 2022 and 2021, the options were granted with an exercise price equal to par value of NIS 0.01 ($0.003).
(b) | The fair value of each stock option granted is computed on the date of grant according to the Black-Scholes option pricing model with the following assumptions:
|  | Years Ended December 31, |
|  | 2 0 2 3 |  |  | 2 0 2 2 |  |  | 2 0 2 1 |
Dividend yield |  |  | 10.48 | % |  |  | 9.69 | % |  |  | 8.73 | %
Expected volatility* |  |  | 51 | % |  |  | 30 | % |  |  | 34 | %
Average risk-free interest rate |  |  | 4.53 | % |  |  | 1.99 | % |  |  | 0.81 | %
Expected average term - in years |  |  | 3.88 |  |  |  | 3.88 |  |  |  | 3.88 |
* | Volatility is based on the historical volatility of the Company’s share price for periods matching the expected term of the option until exercise.
As of December 31, 2023, there were approximately $517 thousand of total unrecognized compensation costs, net of expected forfeitures, related to unvested share-based compensation awards granted under the 2011 Share Incentive Plan. The costs are expected to be recognized over a weighted average period of 1.29 years.
| 2) | The following table summarizes information about options outstanding and exercisable as of December 31, 2023:
|  |  | Options Outstanding |  |  | Options Exercisable |
|  |  | Number |  |  | Weighted |  |  |  |  |  | Number |  |  | Weighted |  |  |  |
|  |  | outstanding |  |  | average |  |  | Weighted |  |  | exercisable |  |  | average |  |  | Weighted |
Range of |  |  | at |  |  | remaining |  |  | average |  |  | at |  |  | remaining |  |  | average |
exercise |  |  | December 31, |  |  | contractual |  |  | exercise |  |  | December 31, |  |  | contractual |  |  | exercise |
prices |  |  | 2 0 2 3 |  |  | life |  |  | price |  |  | 2 0 2 3 |  |  | life |  |  | price |
|  |  |  |  |  | Years |  |  |  |  |  |  |  |  | Years |  |  |  |
$ | 0.003 |  |  |  | 501,000 |  |  |  | 3.27 |  |  | $ | 0.003 |  |  |  | 30,000 |  |  |  | 1.45 |  |  | $ | 0.003 |
The total intrinsic value of options exercised during the years ended December 31, 2023, 2022 and 2021 were approximately $129 thousand, $184 thousand and $235 thousand, respectively. As of December 31, 2023 the aggregate intrinsic value of the outstanding options is $980 thousand, and the aggregate intrinsic value of the exercisable options is $59 thousand.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration